Finance

Lists
CARL:NASDAQ
Carlsmed Inc
$17.42
+1.16%
(+0.20) 1D
$17.42
0.00% (0.00)
After hours
Closed: Nov 20, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CARL...
Open
$17.30
High
$18.25
Low
$16.91
Mkt. cap
477.38M
Avg. vol.
130.70K
Volume
261.69K
52-wk high
$19.15
52-wk low
$8.50
EPS
-$1.48
Shares outstanding
27.40M
No. of employees
127
Open
$17.30
High
$18.25
Low
$16.91
Mkt. cap
477.38M
Avg. vol.
130.70K
Volume
261.69K
52-wk high
$19.15
52-wk low
$8.50
EPS
-$1.48
Shares outstanding
27.40M
No. of employees
127
News stories
From web sources and news partners
About Carlsmed Inc
CEO-
Employees127
Founded2018
HeadquartersCarlsbad, California, United States
SectorHealth Care
IndustryMedical device
Analyst ratings
Based on 4 analysts giving stock ratings to CARL in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CARL in the last 3 months.
Highest
Current $17.42
$26.00 (+49.25%)
Average
$22.33 (+28.19%)
Lowest
$18.00 (+3.33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Buy
Maintained
-
-
11/11/2026
Matthew O'Brien
Piper Sandler
Buy
Reiterated
$18.00
+3.3%
11/11/2026
Richard Newitter
Truist Financial
Buy
Maintained
$23.00
+32%
11/11/2026
Ryan Zimmerman
BTIG
Buy
Reiterated
$26.00
+49.3%
11/10/2026
David Saxon
Needham
Buy
Reiterated
$17.00
-2.4%
08/06/2026
David Roman
Goldman Sachs
Buy
Maintained
$16.00
-8.2%
05/05/2026
Last report
Nov 10, 2026
Fiscal period
Q3 2026
-$0.11 / -$0.38
+71.09%beat
Revenue / Est. (USD)
21.55M / 19.72M
+9.31%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
15.16M
16.12M
18.94M
21.55M
Cost of goods sold
3.56M
3.69M
4.40M
4.89M
Cost of revenue
3.56M
3.69M
4.40M
4.89M
Research and development expenses
5.26M
5.18M
6.04M
6.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.66M
16.52M
19.54M
22.99M
Operating expense
20.93M
21.70M
25.58M
29.37M
Total operating expenses
24.48M
25.39M
29.98M
34.26M
Operating income
-9.32M
-9.28M
-11.04M
-12.70M
Other non operating income
7.00K
-
-
-
EBT including unusual items
-8.61M
-8.70M
-10.51M
-12.24M
EBT excluding unusual items
-8.61M
-8.70M
-10.51M
-12.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.61M
-8.70M
-10.51M
-12.24M
Net profit margin
-56.80%
-53.96%
-55.49%
-56.81%
Earnings per share
-0.29
-0.26
-0.39
-0.11
Interest and investment income
1.03M
891.00K
839.00K
772.00K
Interest expense
-330.00K
-311.00K
-313.00K
-316.00K
Net interest expenses
698.00K
580.00K
526.00K
456.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.22M
-9.18M
-10.91M
-12.58M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps